Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
Beach C, MacLean D, Majorova D, Melemenidis S, Nambiar DK, Kim RK, Valbuena GN, Guglietta S, Krieg C, Darvish-Damavandi M, Suwa T, Easton A, Hillson LV, McCulloch AK, McMahon RK, Pennel K, Edwards J, O'Cathail SM, Roxburgh CS, Domingo E, Moon EJ, Jiang D, Jiang Y, Zhang Q, Koong AC, Woodruff TM, Graves EE, Maughan T, Buczacki SJ, Stucki M, Le QT, Leedham SJ, Giaccia AJ, Olcina MM.
Beach C, et al. Among authors: o cathail sm.
J Clin Invest. 2024 Aug 15;134(16):e185067. doi: 10.1172/JCI185067.
J Clin Invest. 2024.
PMID: 39145459
Free PMC article.
No abstract available.